City Therapeutics Inc. logo

City Therapeutics Inc.

CTY | NASDAQ
Chart Builder DCF Calculator
$20.90
+$0.19 (+0.92%)
Nov 2, 2026, 12:33 PM ET · Market open
Fiscal Quarter
Period Ending
Q2 2020
Jun 30, 2020
Q1 2020
Mar 31, 2020
Q4 2019
Dec 31, 2019
Q3 2019
Sep 30, 2019
Q2 2019
Jun 30, 2019
Q1 2019
Mar 31, 2019
Q4 2018
Dec 31, 2018
Q3 2018
Sep 30, 2018
Q2 2018
Jun 30, 2018
Q1 2018
Mar 31, 2018
Q4 2017
Dec 31, 2017
Q3 2017
Sep 30, 2017
Q2 2017
Jun 30, 2017
Q1 2017
Mar 31, 2017
Q4 2016
Dec 31, 2016
Q3 2016
Sep 30, 2016
Q2 2016
Jun 30, 2016
Q1 2016
Mar 31, 2016
Q4 2015
Dec 31, 2015
Q3 2015
Sep 30, 2015
Q2 2015
Jun 30, 2015
Q1 2015
Mar 31, 2015
Revenue
524M 1.92B 2.01B 2.04B 2.05B 2.06B 2.11B 2.15B 2.1B 2.13B 2.11B 2.14B 2.13B 2.16B 2.21B 2.23B 2.22B 2.25B 2.24B 2.29B 2.22B 2.22B
Cost of Revenue
490M 473M 613M 630M 588M 607M 661M 697M 702M 707M 696M 742M 723M 720M 738M 757M 731M 708M 703M 734M 743M 692M
Gross Profit
34M 1.45B 1.4B 1.41B 1.46B 1.45B 1.45B 1.45B 1.4B 1.42B 1.42B 1.4B 1.41B 1.44B 1.47B 1.47B 1.49B 1.55B 1.54B 1.55B 1.48B 1.53B
Operating Income
679M 779M 626M 748M 750M 760M 685M 717M 626M 632M 600M 560M 573M 580M 519M 576M 602M 625M 622M 572M 521M 545M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
583M 680M 523M 643M 644M 658M 577M 564M 508M 510M 468M 433M 438M 452M 390M 414M 467M 492M 490M 439M 390M 414M
Net Income
430M 503M 386M 477M 477M 487M 405M 453M 427M 380M 846M 265M 268M 278M 238M 255M 288M 304M 321M 268M 238M 247M
Selling & General & Admin
139M 143M -3.23B 1.29B 1.3B 1.3B 1.43B 1.43B 1.48B 1.5B 1.51B 1.58B 1.56B 1.58B 1.69B 1.65B 1.62B 1.63B 1.62B 1.72B 1.7B 1.67B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
139M 143M -3.23B 1.29B 1.3B 1.3B 1.43B 1.43B 1.48B 1.5B 1.51B 1.58B 1.56B 1.58B 1.69B 1.65B 1.62B 1.63B 1.62B 1.72B 1.7B 1.67B
Interest Expense
n/a n/a -286M 95M 96M 95M 98M 112M 120M 118M 117M 117M 117M 114M 116M 121M 120M 121M 117M 119M 119M 118M
Selling & Marketing Expenses
n/a n/a n/a 1.16B 1.14B 1.14B 1.23B 1.26B 1.26B 1.28B 1.3B 1.35B 1.33B 1.34B 1.38B 1.42B 1.39B 1.38B 1.39B 1.45B 1.45B 1.4B
Cost & Expenses
1.12B 1.14B 1.39B 1.92B 1.89B 1.9B 2.09B 2.13B 2.18B 2.21B 2.21B 2.32B 2.28B 2.3B 2.43B 2.41B 2.35B 2.34B 2.32B 2.45B 2.44B 2.36B
Income Tax Expense
153M 177M 137M 166M 167M 171M 172M 111M 81M 130M -378M 168M 170M 174M 152M 159M 179M 188M 169M 171M 152M 167M
Shares Outstanding (Basic)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Diluted)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EPS (Basic)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EPS (Diluted)
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA
910M 1.01B 584M 1.08B 1.08B 1.09B 1.03B 1.04B 989M 988M 985M 947M 950M 955M 926M 958M 1.01B 1.03B 1.07B 1.02B 968M 988M
EBIT
n/a n/a 237M 738M 740M 753M 675M 676M 628M 628M 585M 550M 555M 566M 506M 535M 587M 613M 607M 558M 509M 532M
Depreciation & Amortization
327M 328M 347M 344M 337M 336M 356M 360M 361M 360M 400M 397M 395M 389M 420M 423M 421M 415M 462M 462M 459M 456M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.